New Inhalable Insulin Getting Ready for Clinical Trials


By: dhtest

On June 22, 2006, Generex Biotechnology announced it had signed an agreement with Cardinal Health to manufacture clinical trial batches of Generex Oral-lyn, an inhalable insulin spray that is already available in the country of Ecuador.

For more information, log on to



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.